Delivery Order SPE2DB22D2211-SPE2DB25FSDNB
- Not listed
- The Defense Logistics Agency awarded a $1,885.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Duramorph 5 mg/10 mL ampules on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded contract, which carries no set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Duramorph is a morphine sulfate injectable pharmaceutical product used for pain management in medical settings,...
- The Defense Logistics Agency awarded a $1,150.31 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Duramorph 10 mg/10 mL ampuls. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), was competitively awarded without set-aside designation and carries an ultimate completion date of August 8, 2025. Performance will take place at AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Duramorph 10 mg/10 mL ampules with a ceiling value of $2,884.51. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents performance at the vendor's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,251.88 to AmerisourceBergen Drug Corp for the supply of Duramorph 10 mg/10 mL ampules. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the vendor's pharmaceutical supply services to support federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,581.99 to AmerisourceBergen Drug Corp for Duramorph 5 mg/10 mL ampuls on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- AmerisourceBergen Drug Corp was awarded a competitively procured delivery order valued at $3,648.30 for Duramorph 5 mg/10 mL ampules through the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 8, 2025. This award represents a firm fixed-price delivery order with no set-aside designation, sourced to the vendor's corporate office located in Conshohocken, Pennsylvania. The pharmaceutical product will support federal medical procurement...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DURAMORPH 5 MG/10 ML AMPUL 10ML pharmaceuticals. The contract has a potential value of $3,563.40 and a completion date of February 14, 2024. This delivery order contract is under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product. The award, valued at $1,130.00, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,234.94, is for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a prescription opioid medication. The contract is a firm fixed-price arrangement with a completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $745.52 to Amerisourcebergen Drug Corporation for 4561817352 Duramorph 10 mg/10 ml ampuls. The delivery order calls for 10 ml ampuls of the narcotic analgesic Duramorph to be delivered by August 15, 2023 with performance taking place in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will perform as the prime contractor for this requirement in support of the Defense Logistics Agency's medical supply...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDNBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,124.50 to AmerisourceBergen Drug Corp for DURAMORPH 5 mg/10 ml ampules on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DURAMORPH (morphine sulfate) is a controlled pharmaceutical used for pain management in medical and military healthcare settings. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio reflects its capability to fulfill diverse pharmaceutical requirements through competitive procurement processes with pricing structures ranging from small transactions to substantial orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/25/25 |